BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 23455057)

  • 1. Microwave-assisted synthesis of arene ruthenium(II) complexes that induce S-phase arrest in cancer cells by DNA damage-mediated p53 phosphorylation.
    Wu Q; Fan C; Chen T; Liu C; Mei W; Chen S; Wang B; Chen Y; Zheng W
    Eur J Med Chem; 2013 May; 63():57-63. PubMed ID: 23455057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA-binding, photocleavage, cytotoxicity in vitro, apoptosis and cell cycle arrest studies of symmetric ruthenium(II) complexes.
    Xie YY; Huang HL; Yao JH; Lin GJ; Jiang GB; Liu YJ
    Eur J Med Chem; 2013 May; 63():603-10. PubMed ID: 23567948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microwave-assisted synthesis of arene ruthenium(II) complexes [(η⁶-RC₆H₅)Ru(m-MOPIP)Cl]Cl (R = -H and -CH₃) as groove binder to c-myc G4 DNA.
    Wu Q; Chen T; Zhang Z; Liao S; Wu X; Wu J; Mei W; Chen Y; Wu W; Zeng L; Zheng W
    Dalton Trans; 2014 Jun; 43(24):9216-25. PubMed ID: 24818221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tuning the reactivity of osmium(II) and ruthenium(II) arene complexes under physiological conditions.
    Peacock AF; Habtemariam A; Fernández R; Walland V; Fabbiani FP; Parsons S; Aird RE; Jodrell DI; Sadler PJ
    J Am Chem Soc; 2006 Feb; 128(5):1739-48. PubMed ID: 16448150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, DNA-binding and topoisomerase inhibitory activity of ruthenium(II) polypyridyl complexes.
    Du KJ; Wang JQ; Kou JF; Li GY; Wang LL; Chao H; Ji LN
    Eur J Med Chem; 2011 Apr; 46(4):1056-65. PubMed ID: 21295892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticancer activity of hydrogen-bond-stabilized half-sandwich Ru(II) complexes with heterocycles.
    Mitra R; Das S; Shinde SV; Sinha S; Somasundaram K; Samuelson AG
    Chemistry; 2012 Sep; 18(39):12278-91. PubMed ID: 22903299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dimetallic Ru(II) arene complexes appended on bis-salicylaldimine induce cancer cell death and suppress invasion via p53-dependent signaling.
    Rahman FU; Bhatti MZ; Ali A; Duong HQ; Zhang Y; Ji X; Lin Y; Wang H; Li ZT; Zhang DW
    Eur J Med Chem; 2018 Sep; 157():1480-1490. PubMed ID: 30282320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The contrasting chemistry and cancer cell cytotoxicity of bipyridine and bipyridinediol ruthenium(II) arene complexes.
    Bugarcic T; Habtemariam A; Stepankova J; Heringova P; Kasparkova J; Deeth RJ; Johnstone RD; Prescimone A; Parkin A; Parsons S; Brabec V; Sadler PJ
    Inorg Chem; 2008 Dec; 47(24):11470-86. PubMed ID: 19007206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heteroleptic arene ruthenium complexes based on meso-substituted dipyrrins: synthesis, structure, reactivity, and electrochemical studies.
    Yadav M; Singh AK; Maiti B; Pandey DS
    Inorg Chem; 2009 Aug; 48(16):7593-603. PubMed ID: 19610658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, characterization, and in vitro evaluation of novel ruthenium(II) eta6-arene imidazole complexes.
    Vock CA; Scolaro C; Phillips AD; Scopelliti R; Sava G; Dyson PJ
    J Med Chem; 2006 Sep; 49(18):5552-61. PubMed ID: 16942028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, characterization and biological evaluation of novel Ru(II)-arene complexes containing intercalating ligands.
    Nikolić S; Rangasamy L; Gligorijević N; Aranđelović S; Radulović S; Gasser G; Grgurić-Šipka S
    J Inorg Biochem; 2016 Jul; 160():156-65. PubMed ID: 26818702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery and investigation of anticancer ruthenium-arene Schiff-base complexes via water-promoted combinatorial three-component assembly.
    Chow MJ; Licona C; Yuan Qiang Wong D; Pastorin G; Gaiddon C; Ang WH
    J Med Chem; 2014 Jul; 57(14):6043-59. PubMed ID: 25023617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of the role of Bax, p21/Waf1 and p53 as determinants of cellular responses in HCT116 colorectal cancer cells exposed to the novel cytotoxic ruthenium(II) organometallic agent, RM175.
    Hayward RL; Schornagel QC; Tente R; Macpherson JS; Aird RE; Guichard S; Habtemariam A; Sadler P; Jodrell DI
    Cancer Chemother Pharmacol; 2005 Jun; 55(6):577-83. PubMed ID: 15726367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationships for cytotoxic ruthenium(II) arene complexes containing N,N-, N,O-, and O,O-chelating ligands.
    Habtemariam A; Melchart M; Fernandez R; Parsons S; Oswald ID; Parkin A; Fabbiani FP; Davidson JE; Dawson A; Aird RE; Jodrell DI; Sadler PJ
    J Med Chem; 2006 Nov; 49(23):6858-68. PubMed ID: 17154516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenanthroline ligands are biologically more active than their corresponding ruthenium(II) arene complexes.
    Valladolid J; Hortigüela C; Busto N; Espino G; Rodríguez AM; Leal JM; Jalón FA; Manzano BR; Carbayo A; García B
    Dalton Trans; 2014 Feb; 43(6):2629-45. PubMed ID: 24327227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Half-sandwich Ru II[9]aneS3 complexes structurally similar to antitumor-active organometallic piano-stool compounds: preparation, structural characterization and in vitro cytotoxic activity.
    Bratsos I; Jedner S; Bergamo A; Sava G; Gianferrara T; Zangrando E; Alessio E
    J Inorg Biochem; 2008; 102(5-6):1120-33. PubMed ID: 18279961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ruthenium-Arene-β-Carboline Complexes as Potent Inhibitors of Cyclin-Dependent Kinase 1: Synthesis, Characterization and Anticancer Mechanism Studies.
    He L; Liao SY; Tan CP; Ye RR; Xu YW; Zhao M; Ji LN; Mao ZW
    Chemistry; 2013 Sep; 19(36):12152-60. PubMed ID: 23878093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Picolinate ruthenium(II)-arene complex with in vitro antiproliferative and antimetastatic properties: comparison to a series of ruthenium(II)-arene complexes with similar structure.
    Gligorijević N; Aranđelović S; Filipović L; Jakovljević K; Janković R; Grgurić-Šipka S; Ivanović I; Radulović S; Tešić ZLj
    J Inorg Biochem; 2012 Mar; 108():53-61. PubMed ID: 22266461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ruthenium(II)-arene complexes with functionalized pyridines: synthesis, characterization and cytotoxic activity.
    Grgurić-Sipka S; Ivanović I; Rakić G; Todorović N; Gligorijević N; Radulović S; Arion VB; Keppler BK; Tesić ZLj
    Eur J Med Chem; 2010 Mar; 45(3):1051-8. PubMed ID: 20053483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ruthenium(II) carbonyl complexes containing S-methylisothiosemicarbazone based tetradentate ligand: synthesis, characterization and biological applications.
    Selvamurugan S; Ramachandran R; Viswanathamurthi P
    Biometals; 2013 Oct; 26(5):741-53. PubMed ID: 23780567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.